DE69329212T2 - Perkutanes Salbenpräparat in Form eines haftenden Streifens - Google Patents

Perkutanes Salbenpräparat in Form eines haftenden Streifens

Info

Publication number
DE69329212T2
DE69329212T2 DE69329212T DE69329212T DE69329212T2 DE 69329212 T2 DE69329212 T2 DE 69329212T2 DE 69329212 T DE69329212 T DE 69329212T DE 69329212 T DE69329212 T DE 69329212T DE 69329212 T2 DE69329212 T2 DE 69329212T2
Authority
DE
Germany
Prior art keywords
percutaneous
alcohol
ointment preparation
percutaneous absorption
isdn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329212T
Other languages
German (de)
English (en)
Other versions
DE69329212D1 (de
Inventor
Yasunori Morimoto
Kenji Sugibayashi
Masatosi Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toko Yakuhin Kogyo KK
Original Assignee
Toko Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toko Yakuhin Kogyo KK filed Critical Toko Yakuhin Kogyo KK
Publication of DE69329212D1 publication Critical patent/DE69329212D1/de
Application granted granted Critical
Publication of DE69329212T2 publication Critical patent/DE69329212T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69329212T 1992-03-26 1993-03-19 Perkutanes Salbenpräparat in Form eines haftenden Streifens Expired - Fee Related DE69329212T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10040092A JP3523275B2 (ja) 1992-03-26 1992-03-26 貼付剤

Publications (2)

Publication Number Publication Date
DE69329212D1 DE69329212D1 (de) 2000-09-21
DE69329212T2 true DE69329212T2 (de) 2001-04-05

Family

ID=14272939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329212T Expired - Fee Related DE69329212T2 (de) 1992-03-26 1993-03-19 Perkutanes Salbenpräparat in Form eines haftenden Streifens

Country Status (5)

Country Link
US (1) US5419912A (https=)
EP (1) EP0563024B1 (https=)
JP (1) JP3523275B2 (https=)
DE (1) DE69329212T2 (https=)
TW (1) TW287101B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69413661T2 (de) * 1993-12-30 1999-06-17 Rotta Research B.V., Amsterdam Transdermales Pflaster mit Isosorbiddinitrat als aktivem Bestandteil
JP3604177B2 (ja) * 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
JPH09169635A (ja) * 1995-12-20 1997-06-30 Sekisui Chem Co Ltd 経皮吸収製剤
US6217707B1 (en) 1996-12-31 2001-04-17 Kimberly-Clark Worldwide, Inc. Controlled coverage additive application
US6231719B1 (en) 1996-12-31 2001-05-15 Kimberly-Clark Worldwide, Inc. Uncreped throughdried tissue with controlled coverage additive
JP4008532B2 (ja) * 1997-05-12 2007-11-14 帝國製薬株式会社 経皮吸収貼付製剤
JP4136029B2 (ja) * 1997-05-12 2008-08-20 帝國製薬株式会社 硝酸イソソルビド含有貼付剤
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
JP2006001859A (ja) * 2004-06-16 2006-01-05 Shiseido Co Ltd 絆創膏組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS5948416A (ja) * 1982-09-10 1984-03-19 Nitto Electric Ind Co Ltd 医薬製剤
DE69026361T2 (de) * 1989-12-28 1996-08-14 Nitto Denko Corp Gelpräparat für die perkutane Verabreichung
US5204109A (en) * 1989-12-28 1993-04-20 Nitto Denko Corporation Percutaneous gel preparation
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤

Also Published As

Publication number Publication date
US5419912A (en) 1995-05-30
TW287101B (https=) 1996-10-01
DE69329212D1 (de) 2000-09-21
EP0563024B1 (en) 2000-08-16
EP0563024A1 (en) 1993-09-29
JP3523275B2 (ja) 2004-04-26
JPH05271070A (ja) 1993-10-19

Similar Documents

Publication Publication Date Title
DE3685545T2 (de) System zur transdermalen abgabe von nitroglycerin.
DE69801893T2 (de) Ölige Pflaster mit NA-Diclofenac zur äusseren Anwendung
DE69615399T2 (de) Triacetin zur erhöhung der transdermalen penetration
DE69736671T2 (de) Transdermale arzneistoffverabreichungsmatrix zur gleichzeitigen gabe von estradiol und eines weiteren steroids
DE69329825T2 (de) Zweiphasenmatrix für ein abgabesystem zur verzögerten arzneistofffreisetzung
DE68920109T2 (de) Arzneimittelpräparat für perkutane Absorption.
DE69431209T2 (de) Transdermale prostaglandin-zusammensetzung
DE3416248C2 (de) Vorrichtung zur Abgabe von Wirkstoffen über die Haut und Masse zur Herstellung einer Matrix dieser Vorrichtung
DE4241874C2 (de) Medizinisches Pflaster für die perkutane Verabreichung des Wirkstoffs Ketoprofen
DE69232685T2 (de) Pflaster enthaltend Anthranilsäure-Derivate zur Förderung der perkutanen Absorption
DE69625483T3 (de) Transdermales pflaster zur verabreichung von 17-deacetyl norgestimat in kombination mit einem östrogen
DE69010076T2 (de) Transdermales therapeutisches Mittel.
DE68917292T2 (de) Transdermales estradiol als therapeutisches sytem.
DE69822327T2 (de) Transdermales arzneistoff-abgabesystem für ein entzündungshemmendes analgetisches mittel enthaltend diclofenac diethylammonium salz, und verfahren zu dessen herstellung
DE69320096T2 (de) Verabreichungssystem für Östradiol
DE69715049T2 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DE69329212T2 (de) Perkutanes Salbenpräparat in Form eines haftenden Streifens
DE69815263T2 (de) Stabile zubereitung auf basis von acetylsalicylsäure zur äusseren anwendung
DE3880212T2 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
DE68907312T2 (de) Bunazosin oder seine Salze enthaltende pharmazeutische Zubereitungen zur perkutanen Verabreichung.
EP0341202A1 (de) Transdermale Monolithsysteme
EP0617972A2 (de) Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)-acrylat-Mischung
DE68911499T2 (de) Topisch anzuwendende Zubereitungen und Systeme zur transdermalen Verabreichung enthaltend 1-Isobutyl-1H-imidazo[4,5-c]chinolin-4-amine.
DE3587698T2 (de) Pharmazeutische Präparate.
DE69617252T2 (de) Transdermales matrixsystem

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee